首页> The oncologist> Approval summary: Letrozole (Femara? Tablets) for adjuvant and extended adjuvant postmenopausal breast cancer treatment: Conversion of accelerated to full approval

Approval summary: Letrozole (Femara? Tablets) for adjuvant and extended adjuvant postmenopausal breast cancer treatment: Conversion of accelerated to full approval

导出原文传递

翻译打印收藏纠错

第一作者： Cohen,M.H.

作者： Cohen,M.H. ^[1] ; Johnson,J.R. ; Justice,R. ; Pazdur,R.

作者单位： Office of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug ^[1]

关键词 Adjuvant treatment Femara?Letrozole Postmenopausal breast cancer

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

The oncologist

2011年16卷12期

1762-1770页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

The oncologist

2011年16卷12期

1762-1770页

检索历史清除

Approval summary: Letrozole (Femara? Tablets) for adjuvant and extended adjuvant postmenopausal breast cancer treatment: Conversion of accelerated to full approval

The oncologist

相似文献

同项目论文

The oncologist

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Approval summary: Letrozole (Femara? Tablets) for adjuvant and extended adjuvant postmenopausal breast cancer treatment: Conversion of accelerated to full approval

The oncologist

相似文献

同项目论文

The oncologist

相关期刊

检索历史清除